Gal-3 expression has been recognized as a promising diagnostic molecular marker of thyroid malignancy due to its differential expression between thyroid carcinomas and normal or benign thyroid tissues [29,45,46,47]. The gene discussed is LGALS3; the disease is thyroid gland disorder.